Pilot Study to Assess the Feasibility of Randomizing Extended Length of Stay in Medically Managed Opioid Withdrawal
How to cite
Jacobson, Mireille; Chang, Tom; Powell, David. 2025. "Pilot Study to Assess the Feasibility of Randomizing Extended Length of Stay in Medically Managed Opioid Withdrawal." AEA RCT Registry. AEARCTR-0016250. https://doi.org/10.1257/rct.16250-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Provisional CDC data indicate that nationwide opioid overdose deaths declined rapidly between December 2023 and 2024, but overdose deaths remain high and many individuals still struggle with opioid use disorder. In this collaboration with Pierce County, WA, the second most populous county in Washington, and the Metropolitan Development Council (MDC), a social service provider in the county, we will test the feasibility of randomizing length of stay for individuals undergoing medically managed withdrawal (detox) from fentanyl. While providers of medically managed detox services believe that 10-15 days constitute the optimal length of stay, insurers typically only cover detox stays of five days and some patients leave even prior to that. This work will assess whether expanding coverage to more than five days can increase the completed length of stay in detox. We will also collect and analyze data on the reasons people leave detox “Against Medical Advice” or AMA. Findings will inform a larger study on the impact of detox length of stay on patient outcomes such as entry into treatment, return to detox and health care utilization. It will also generate insights into strategies to reduce AMA departures.
Intervention
Patients presenting for medically managed detox from fentanyl will be randomized to a standard or extend length of stay. Staff provide details on the covered length of stay at a planning meeting that usually occurs on the 2nd day in detox. We will provide a randomization sequence for length of stay offers to patients who are admitted for detox from fentanyl. Patients admitted for detox from other substances, most commonly alcohol or some combination of substances, will not be included in the offer per Pierce County and MDC agreement.
Experimental design
Patients presenting for medically managed detox from fentanyl will be randomized to coverage of a standard detox stay or and extend length of stay.
Design details
Cited by
No citation data available for this registration yet.